MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1201 to 1220 of 166,322 approvalsPage 61 of 8317

Polyvinyl Alcohol Eye Drops

Approval Number: 国药准字H20253595
Registration: Mar 11, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字HJ20250025
Registration: Mar 11, 2025

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number: 国药准字H20253618
Registration: Mar 11, 2025

Nitroglycerin sublingual tablets

Approval Number: 国药准字H20253612
Registration: Mar 11, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253575
Registration: Mar 11, 2025

Entecavir Oral Solution

Approval Number: 国药准字H20253587
Registration: Mar 11, 2025

Tafluprost Eye Drops

Approval Number: 国药准字H20253582
Registration: Mar 11, 2025

Piracetam Injection

Approval Number: 国药准字H20253599
Registration: Mar 11, 2025

Midazolam Hydrochloride Oral Solution

Approval Number: 国药准字H20253580
Registration: Mar 11, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253574
Registration: Mar 11, 2025

Cloperastine Hydrochloride Tablets

Approval Number: 国药准字H37022333
Registration: Mar 10, 2025

Inosine Tablets

Approval Number: 国药准字H20045676
Registration: Mar 10, 2025

Pipemidic Acid Tablets

Approval Number: 国药准字H41022215
Registration: Mar 10, 2025

消栓口服液

Approval Number: 国药准字Z22025148
Registration: Mar 10, 2025

Metacycline Hydrochloride Tablets

Approval Number: 国药准字H37023632
Registration: Mar 10, 2025

Sodium Bicarbonate Injection

Approval Number: 国药准字H20258026
Registration: Mar 10, 2025

Etofylline Clofibrate Tablets

Approval Number: 国药准字H37020457
Registration: Mar 10, 2025

Aminobutyric Acid Tablets

Approval Number: 国药准字H37023600
Registration: Mar 10, 2025

Oxytetracycline Ointment

Approval Number: 国药准字H37022358
Registration: Mar 10, 2025

Compound Sulfamethoxazole Tablets

Approval Number: 国药准字H35020819
Registration: Mar 6, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.